An intravenous PD-1 inhibiting humanized monoclonal antibody for treatment of adults with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal.
An intravenous PD-1 inhibiting humanized monoclonal antibody for treatment of adults with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal.